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Impact of Raw Materials on Sialyation for a Therapeutic Protein
Wei-Chen Hung, Jessica Kennedy, Loray Paul, John Mavrianos, Bridget Leslie, Mei Shao
Alexion Pharmaceuticals, Inc., New Haven, CT, USA
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Total sialic acid content (TSAC) is a critical product quality attribute (CQA) for a
therapeutic protein. By employing several statistical tools, we are able to
identify certain lots of commercial culture media that cause differential levels of
TSAC. Furthermore, we have identified several key components and their
impact are evaluated in small scale production bioreactors. Overall this study
provides the insight of understanding better control of product quality and
establishes a methodology for identifying the root causes in cell culture media
contributing to the variability of cell performance.
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Total sialic acid content (TSAC) is a critical product quality attribute (CQA) for a
therapeutic Protein manufactured by Alexion.
1. Sialic acid is a generic term for the N- or O-substituted derivatives
of neuraminic acid, a monosaccharide with a nine-carbon backbone.
2. The synthesis/modification is mainly distributed in endoplasmic reticulum
or the Golgi apparatus (Figure 1)
3. It must be tightly controlled for the bulk drug substance (BDS).
4. Study results conducted by Alexion have suggested lot-to-lot variability of
commercial cell culture media have potential effects on total sialic acid
content (TSAC) at cell culture fluid (CCF) and harvested cell culture fluid
(HCCF) steps.
5. Cell culture media, as used in this pipeline, is not chemically well defined,
and is composed of wide array of unknown components.
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Batches using certain lots of media perform differently in TSAC level
1. Polynomial model suggests group II media lots result in low level of TSAC
(Figure 2)

Expected TSAC region

2. Group II media lots resulting in low TSAC were produced in Mar17- Apr17
(Table 1)
3. Multivariate analysis (MVA) suggests that only media groups have the highest
and significant impact on TSAC, in comparison with media supplement and
nutrient feed (Figure 3)
4. Using group II media lots in manufacturing scale results in statistically
significant lower TSAC, compared to group I media lots (Figure 4)

Low TSAC region

Figure 6 : Principle component analysis (PCA)
classifies media lots.
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Figure 2: TSAC trending in manufacturing process
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4.

Raw material lot-to-lot variability could impact cell culture
performance and TSAC levels.
Including levels of trace metals, vitamins, and amino acids in PCA
allows us to identify manufacturing differences of media lots.
PCA provides a contribution ranking of each component for further
evaluation.
Small-scale studies were performed and a potential root cause was
identified .

3.

Continue evaluating top candidates determined by PCA or MVA in small
scale studies.
Concentration and synergetic effects between validated factors should
be carefully evaluated.
Provide feedback and establish collaboration with vendor to improve
the consistency of RM production.
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Figure 7: Contribution evaluation of media components by
selectively analyzing media lots resulting in extremely high
and low TSAC levels.
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Figure 4: Comparison of distribution of TSAC at CCF from
manufacturing cell culture using group I, II, or III of media.
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FUTURE WORK

5. Evaluate the impact of top candidates suggested by PCA on TSAC in a small
scale studies.
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Top Candidate (factor 10) Spiking Experiment to Verify the Effect on TSAC by
Using 2L Small-Scale-Bioreactors.
1. PCA and further analysis suggests that the level of factor 10 ( Figure 8)
could be positively correlated with TSAC level.
2. Day 7 results show that spiking results in high TSAC level in both duplicates
3. For day 10 results, one of the spiking duplicates shows higher TSAC level in
comparison with its corresponding control, while the other demonstrates a
similar level between spiking condition and control.
4. Factor 10 could be one of the root causes but its concentration effect needs
further evaluation.

2.

4. Employ PCA to classify RM lots and determine if ithey shares similar patterns
of TSAC differences.
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CONCLUSIONS

5. Differential viability trending in cell performance is also observed. Batches
using group II media lots demonstrate the lowest viability trending in
comparison with other groups (Figure 5).

p < 0.001

RESULTS

Factor 10-A

Figure 8: Day 7 and Day 10 TSAC results of duplicate spiking
experiments in comparison with controls.

Table 1: overview of media lot production time and
corresponding TSAC level.

Figure 3: Impact evaluation of raw materials including media, media
supplement, and nutrient feed on TSAC at CCF.

METHODS

3. Measure levels of RM components such as trace metals, vitamins, and
amino acids to be included in principle component analysis (PCA).
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2. Monitor differences of the cell performance by grouping raw material lots
that result in differential levels of TSAC.

control-A
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Figure 1: Schematic of glycosylation in cellular compartments.

1. Employ multivariate analysis (MVA) to detect potential lots of raw material
(RM) that cause differential level of TSAC.
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Figure 5: Comparison of viability trending from manufacturing cell
culture using group I, II or III of media.

Principle Component Analysis (PCA) Classifies Media Lots in the Pattern of
TSAC Levels.
1. Levels of trace metals, vitamins, and amino acids of media lots are included
in principle component analysis (PCA).
2. PCA successfully clusters the media lots resulting in low TSAC (Figure 6).
3. Select media lots resulting in extremely high or low TSAC levels for
contribution evaluation. The media lots with extreme TSAC levels are
indicated by arrows (Figure 7).
4. Highly ranked factors are prioritized for TSAC evaluation in small scale (2L)
production bioreactors.
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